How should a 43-year-old male chronic alcoholic with marked hyperbilirubinemia, elevated γ‑glutamyl transpeptidase, AST approximately twice ALT, low albumin, abdominal pain radiating to the back, and icterus be managed?

Acute Alcoholic Hepatitis with Severe Disease - Immediate Hospitalization and Corticosteroid Therapy Required

This patient has acute alcoholic hepatitis (AH) with severe disease requiring immediate hospitalization, infection screening, aggressive nutritional support, and likely corticosteroid therapy based on severity scoring.

Diagnostic Confirmation

The clinical presentation is classic for acute alcoholic hepatitis 1:

• Jaundice with bilirubin 6.53 mg/dL (>3 mg/dL threshold met)
• AST:ALT ratio of 2.1 (95.8/45.5), exceeding the diagnostic threshold of >1.5
• AST 95.8 U/L (within the 50-400 U/L range typical for AH)
• Markedly elevated GGT 764.3 U/L indicating ongoing alcohol-related liver injury
• Hypoalbuminemia 2.54 g/dL suggesting chronic liver disease with acute decompensation
• Abdominal pain radiating to back - concerning for potential pancreatitis comorbidity

The predominantly conjugated hyperbilirubinemia (direct 4.2 mg/dL) with cholestatic features is consistent with AH, though less common 2, 3.

Critical Immediate Actions

1. Hospitalization is Mandatory 1

This patient requires admission given:

• Severe jaundice indicating decompensation
• Need for abstinence monitoring
• Risk of multi-organ failure (MOF)
• Inadequate outpatient support likely

2. Infection Screening Before Any Treatment 1

Obtain cultures immediately (blood, urine, ascites if present) regardless of fever absence, as:

• Neutrophil dysfunction is common in AH
• Infections precipitate MOF syndrome with very high mortality
• Must be done before considering immunosuppressive therapy

3. Calculate Severity Scores 1

You need the INR/PT to calculate:

• Maddrey Discriminant Function (MDF) = 4.6 × (PT - control PT) + bilirubin (mg/dL)
  • MDF >32 indicates severe disease with 28-day mortality >50% without treatment
• MELD score = 3.78×ln(bilirubin) + 11.2×ln(INR) + 9.57×ln(creatinine) + 6.43
  • MELD >20 predicts high 90-day mortality
  • MELD >26 warrants liver transplant evaluation 1

Critical pitfall: The low ALP (46 U/L) is unusual but doesn't exclude AH; focus on the AST:ALT ratio and clinical syndrome 2.

Imaging Requirements

Urgent Abdominal Imaging Needed 1

• Ultrasound preferred (least invasive, no contrast risk)
• Avoid iodinated contrast - increases acute kidney injury risk
• Purpose: Rule out biliary obstruction, assess for ascites, evaluate pancreas given back pain

The abdominal pain radiating to back raises concern for concurrent acute pancreatitis, common in alcoholics and can complicate management.

Nutritional Intervention - Non-Negotiable

Aggressive Nutritional Support 1

• 1.0-1.5 g protein/kg body weight daily
• 30-40 kcal/kg body weight daily
• If unable to eat due to anorexia: nasogastric/nasoenteric feeding tube
• Parenteral nutrition alone is inadequate
• Supplement with B vitamins and folic acid

Malnutrition is universal and directly impacts mortality.

Pharmacologic Management Algorithm

If MDF >32 or MELD >20 (Severe Disease):

Corticosteroid Therapy 1:

• Methylprednisolone 32 mg daily (or prednisolone 40 mg daily)
• Only if no contraindications:
  • No active infection (hence the culture requirement)
  • No hepatitis B
  • No tuberculosis
  • No gastrointestinal bleeding
• Assess response at Day 7 using Lille score
• Discontinue if no improvement by Lille criteria
• Benefit is modest and limited to <28 days

If Contraindications to Corticosteroids:

• Pentoxifylline 400 mg three times daily with meals 1
• Evidence is conflicting but represents alternative option

If MDF <32 and MELD <20 (Mild-Moderate Disease):

• No corticosteroids indicated 1
• Focus on abstinence counseling
• High-protein diet with vitamin supplementation
• Close outpatient follow-up

Critical Supportive Measures

Avoid Nephrotoxic Agents 1

• Minimize or avoid diuretics - AKI is early manifestation of MOF
• Monitor creatinine closely
• Maintain adequate hydration

Monitor for SIRS and MOF 1

The presence of systemic inflammatory response syndrome predicts MOF development with extremely high mortality.

Liver Transplant Consideration

If MELD >26 with severe disease 1:

• Refer for liver transplant evaluation
• Requirements: Good insight into alcohol use disorder, strong social support
• 90-day mortality without transplant is extremely high
• Outcomes comparable to other transplant recipients with similar MELD scores
• Some centers require defined abstinence period

Alcohol Cessation - The Cornerstone

Absolute abstinence is mandatory 1:

• Single most important intervention
• Can be monitored via urine or hair ethyl glucuronide (EtG) 2
• Even if complete abstinence fails, reduction improves survival
• Provide addiction medicine consultation

Additional Workup Needed

You must obtain:

• INR/PT (essential for severity scoring)
• Creatinine (for MELD, assess renal function)
• Complete blood count (assess for leukocytosis, anemia, thrombocytopenia)
• Hepatitis B and C serologies (rule out viral coinfection)
• Consider lipase given back pain (rule out pancreatitis)

Prognosis Discussion

Without treatment and continued drinking: 40-50% mortality at 90 days 1. Even with optimal treatment, 1-year mortality approaches 56% 1. This underscores the severity and need for aggressive intervention including potential transplant evaluation.

The combination of jaundice, hypoalbuminemia, and chronic alcoholism represents decompensated liver disease - an ominous sign requiring immediate specialist gastroenterology/hepatology involvement 2, 4.